As WTAP mRNA expression is not elevated in AML [54], this latter mechanism might be relevant to increase WTAP protein levels concomitantly to the METTL3/METTL14 core complex and sustain its oncogenic role in AML. This evidence concerns the gene METTL14 and acute myeloid leukemia.